Decoding treatment non-response in spondyloarthritis.
文献摘要
The term spondyloarthritis refers to a spectrum of inflammatory diseases, including axial spondyloarthritis and psoriatic arthritis, in which musculoskeletal and extra-musculoskeletal manifestations coexist. Targeted therapies have improved outcomes, yet many patients achieve only a partial response and sustained remission remains uncommon, irrespective of the drug mode of action used. Observations of repeated treatment failures have given rise to the concepts of difficult-to-manage and treatment-refractory disease, but non-response itself is inconsistently defined and is often treated as a single phenomenon. However, treatment non-response is a heterogeneous construct that needs to be unravelled by first differentiating apparent from true non-response. Four distinct clinical patterns of true non-response can be identified - primary non-response, secondary loss of response, divergent responses across disease domains and paradoxical reactions - shaped to differing extents by drug exposure, dependence on the targeted pathway and anatomical compartmentalization. Recognizing these patterns and likely mechanistic underpinnings could support more rational treatment selection, limit unnecessary switching of targeted therapies and inform future biomarker-driven strategies to anticipate and ultimately prevent non-response.